Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 504 entries
Sorted by: Best Match Show Resources per page
The nursing shortage.

Journal of intravenous nursing : the official publication of the Intravenous Nurses Society

Larkin M.
PMID: 2723869
J Intraven Nurs. 1989 May-Jun;12(3):131, 142.

No abstract available.

Cite
Larkin M. The nursing shortage. J Intraven Nurs. 1989;12(3):131, 142
Larkin, M. (1989). The nursing shortage. Journal of intravenous nursing : the official publication of the Intravenous Nurses Society, 12(3), 131, 142.
Larkin, M. "The nursing shortage." Journal of intravenous nursing : the official publication of the Intravenous Nurses Society vol. 12,3 (1989): 131, 142.
Larkin M. The nursing shortage. J Intraven Nurs. 1989 May-Jun;12(3):131, 142. PMID: 2723869.
Copy Download .nbib Format: NLM
Post-Traumatic, Drug-Resistant Epilepsy and Review of Seizure Control Outcomes from Blinded, Randomized Controlled Trials of Brain Stimulation Treatments for Drug-Resistant Epilepsy.

Cureus

Larkin M, Meyer RM, Szuflita NS, Severson MA, Levine ZT.
PMID: 27672534
Cureus. 2016 Aug 22;8(8):e744. doi: 10.7759/cureus.744.

BACKGROUND: Many post-traumatic epilepsy (PTE) patients become resistant to medications. Nervous stimulation as a treatment for drug-resistant epilepsy (DRE) is an active area of clinical investigation.OBJECTIVE: To summarize methods, reported seizure control outcome measures, and adverse events from blinded,...

Cite
Larkin M, Meyer RM, Szuflita NS, et al. Post-Traumatic, Drug-Resistant Epilepsy and Review of Seizure Control Outcomes from Blinded, Randomized Controlled Trials of Brain Stimulation Treatments for Drug-Resistant Epilepsy. Cureus. 2016;8(8):e744doi: 10.7759/cureus.744.
Larkin, M., Meyer, R. M., Szuflita, N. S., Severson, M. A., & Levine, Z. T. (2016). Post-Traumatic, Drug-Resistant Epilepsy and Review of Seizure Control Outcomes from Blinded, Randomized Controlled Trials of Brain Stimulation Treatments for Drug-Resistant Epilepsy. Cureus, 8(8), e744. https://doi.org/10.7759/cureus.744
Larkin, Michael, et al. "Post-Traumatic, Drug-Resistant Epilepsy and Review of Seizure Control Outcomes from Blinded, Randomized Controlled Trials of Brain Stimulation Treatments for Drug-Resistant Epilepsy." Cureus vol. 8,8 (2016): e744. doi: https://doi.org/10.7759/cureus.744
Larkin M, Meyer RM, Szuflita NS, Severson MA, Levine ZT. Post-Traumatic, Drug-Resistant Epilepsy and Review of Seizure Control Outcomes from Blinded, Randomized Controlled Trials of Brain Stimulation Treatments for Drug-Resistant Epilepsy. Cureus. 2016 Aug 22;8(8):e744. doi: 10.7759/cureus.744. PMID: 27672534; PMCID: PMC5035081.
Copy Download .nbib Format: NLM
Response to Soloff.

Psychiatry

Yeomans F, Selzer M, Clarkin J.
PMID: 27707113
Psychiatry. 1993 Aug;56(3):268-269. doi: 10.1080/00332747.1993.11024644.

No abstract available.

Cite
Yeomans F, Selzer M, Clarkin J. Response to Soloff. Psychiatry. 1993;56(3):268-269doi: 10.1080/00332747.1993.11024644.
Yeomans, F., Selzer, M., & Clarkin, J. (1993). Response to Soloff. Psychiatry, 56(3), 268-269. https://doi.org/10.1080/00332747.1993.11024644
Yeomans, Frank, et al. "Response to Soloff." Psychiatry vol. 56,3 (1993): 268-269. doi: https://doi.org/10.1080/00332747.1993.11024644
Yeomans F, Selzer M, Clarkin J. Response to Soloff. Psychiatry. 1993 Aug;56(3):268-269. doi: 10.1080/00332747.1993.11024644. PMID: 27707113.
Copy Download .nbib Format: NLM
Pancreatocolonic fistulization secondary to pancreatic adenocarcinoma presenting as unexplained halitosis.

Radiology case reports

Manov J, Langston M, Roth P, Barkin J, Kuker R, Barkin JS.
PMID: 29487640
Radiol Case Rep. 2017 Dec 25;13(1):72-75. doi: 10.1016/j.radcr.2017.11.011. eCollection 2018 Feb.

Pancreatic cancer is often detected in late stages, which contributes to its grim prognosis. Although the manifestations of pancreatic cancer most often include nonspecific gastrointestinal complaints, we report a case with the sole initial complaint of halitosis and subsequent...

Cite
Manov J, Langston M, Roth P, et al. Pancreatocolonic fistulization secondary to pancreatic adenocarcinoma presenting as unexplained halitosis. Radiol Case Rep. 2017;13(1):72-75doi: 10.1016/j.radcr.2017.11.011.
Manov, J., Langston, M., Roth, P., Barkin, J., Kuker, R., & Barkin, J. S. (2018). Pancreatocolonic fistulization secondary to pancreatic adenocarcinoma presenting as unexplained halitosis. Radiology case reports, 13(1), 72-75. https://doi.org/10.1016/j.radcr.2017.11.011
Manov, John, et al. "Pancreatocolonic fistulization secondary to pancreatic adenocarcinoma presenting as unexplained halitosis." Radiology case reports vol. 13,1 (2018): 72-75. doi: https://doi.org/10.1016/j.radcr.2017.11.011
Manov J, Langston M, Roth P, Barkin J, Kuker R, Barkin JS. Pancreatocolonic fistulization secondary to pancreatic adenocarcinoma presenting as unexplained halitosis. Radiol Case Rep. 2017 Dec 25;13(1):72-75. doi: 10.1016/j.radcr.2017.11.011. eCollection 2018 Feb. PMID: 29487640; PMCID: PMC5826695.
Copy Download .nbib Format: NLM
Examine the patient not the hernia: identification of an asymptomatic giant primary retroperitoneal pseudocyst. A case report and literature review.

Journal of surgical case reports

Karim L, Larkin D, Sadat M.
PMID: 27190202
J Surg Case Rep. 2016 May 17;2016(5). doi: 10.1093/jscr/rjw092.

We present the case of a 70-year-old man with a giant right-sided retroperitoneal pseudocyst, confirmed histologically after resection to be benign with appearances dissimilar to pancreatic and adrenal tissue. The cyst was noted incidentally on table at the time...

Cite
Karim L, Larkin D, Sadat M. Examine the patient not the hernia: identification of an asymptomatic giant primary retroperitoneal pseudocyst. A case report and literature review. J Surg Case Rep. 2016;2016(5)doi: 10.1093/jscr/rjw092.
Karim, L., Larkin, D., & Sadat, M. (2016). Examine the patient not the hernia: identification of an asymptomatic giant primary retroperitoneal pseudocyst. A case report and literature review. Journal of surgical case reports, 2016(5), . https://doi.org/10.1093/jscr/rjw092
Karim, Lawen, et al. "Examine the patient not the hernia: identification of an asymptomatic giant primary retroperitoneal pseudocyst. A case report and literature review." Journal of surgical case reports vol. 2016,5 (2016). doi: https://doi.org/10.1093/jscr/rjw092
Karim L, Larkin D, Sadat M. Examine the patient not the hernia: identification of an asymptomatic giant primary retroperitoneal pseudocyst. A case report and literature review. J Surg Case Rep. 2016 May 17;2016(5). doi: 10.1093/jscr/rjw092. PMID: 27190202; PMCID: PMC4869591.
Copy Download .nbib Format: NLM
SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function.

Frontiers in immunology

Ahmed CM, Larkin J, Johnson HM.
PMID: 25954276
Front Immunol. 2015 Apr 21;6:183. doi: 10.3389/fimmu.2015.00183. eCollection 2015.

Suppressors of cytokine signaling (SOCS) are inducible intracellular proteins that play essential regulatory roles in both immune and non-immune function. Of the eight known members, SOCS1 and SOCS3 in conjunction with regulatory T cells play key roles in regulation...

Cite
Ahmed CM, Larkin J, Johnson HM. SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function. Front Immunol. 2015;6:183doi: 10.3389/fimmu.2015.00183.
Ahmed, C. M., Larkin, J., & Johnson, H. M. (2015). SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function. Frontiers in immunology, 6183. https://doi.org/10.3389/fimmu.2015.00183
Ahmed, Chulbul M I, et al. "SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function." Frontiers in immunology vol. 6 (2015): 183. doi: https://doi.org/10.3389/fimmu.2015.00183
Ahmed CM, Larkin J, Johnson HM. SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function. Front Immunol. 2015 Apr 21;6:183. doi: 10.3389/fimmu.2015.00183. eCollection 2015. PMID: 25954276; PMCID: PMC4404822.
Copy Download .nbib Format: NLM
RBC deformability and amino acid concentrations after hypo-osmotic challenge may reflect chronic cell hydration status in healthy young men.

Physiological reports

Stookey JD, Klein A, Hamer J, Chi C, Higa A, Ng V, Arieff A, Kuypers FA, Larkin S, Perrier E, Lang F.
PMID: 24303184
Physiol Rep. 2013 Oct;1(5):e00117. doi: 10.1002/phy2.117. Epub 2013 Oct 23.

Biomarkers of chronic cell hydration status are needed to determine whether chronic hyperosmotic stress increases chronic disease risk in population-representative samples. In vitro, cells adapt to chronic hyperosmotic stress by upregulating protein breakdown to counter the osmotic gradient with...

Cite
Stookey JD, Klein A, Hamer J, et al. RBC deformability and amino acid concentrations after hypo-osmotic challenge may reflect chronic cell hydration status in healthy young men. Physiol Rep. 2013;1(5):e00117doi: 10.1002/phy2.117.
Stookey, J. D., Klein, A., Hamer, J., Chi, C., Higa, A., Ng, V., Arieff, A., Kuypers, F. A., Larkin, S., Perrier, E., & Lang, F. (2013). RBC deformability and amino acid concentrations after hypo-osmotic challenge may reflect chronic cell hydration status in healthy young men. Physiological reports, 1(5), e00117. https://doi.org/10.1002/phy2.117
Stookey, Jodi D, et al. "RBC deformability and amino acid concentrations after hypo-osmotic challenge may reflect chronic cell hydration status in healthy young men." Physiological reports vol. 1,5 (2013): e00117. doi: https://doi.org/10.1002/phy2.117
Stookey JD, Klein A, Hamer J, Chi C, Higa A, Ng V, Arieff A, Kuypers FA, Larkin S, Perrier E, Lang F. RBC deformability and amino acid concentrations after hypo-osmotic challenge may reflect chronic cell hydration status in healthy young men. Physiol Rep. 2013 Oct;1(5):e00117. doi: 10.1002/phy2.117. Epub 2013 Oct 23. PMID: 24303184; PMCID: PMC3841048.
Copy Download .nbib Format: NLM
Sunitinib in Metastatic Renal Cell Carcinoma: A Systematic Review of UK Real World Data.

Frontiers in oncology

Argyropulo-Palmer M, Jenkins A, Theti DS, Larkin J, Montgomery D.
PMID: 26380224
Front Oncol. 2015 Aug 25;5:195. doi: 10.3389/fonc.2015.00195. eCollection 2015.

BACKGROUND: Real world data (RWD) are increasingly used to inform drug reimbursement decisions, but it is unclear how well outcomes from real world studies compare to those of clinical trials. This systematic review seeks to compare outcomes for sunitinib...

Cite
Argyropulo-Palmer M, Jenkins A, Theti DS, et al. Sunitinib in Metastatic Renal Cell Carcinoma: A Systematic Review of UK Real World Data. Front Oncol. 2015;5:195doi: 10.3389/fonc.2015.00195.
Argyropulo-Palmer, M., Jenkins, A., Theti, D. S., Larkin, J., & Montgomery, D. (2015). Sunitinib in Metastatic Renal Cell Carcinoma: A Systematic Review of UK Real World Data. Frontiers in oncology, 5195. https://doi.org/10.3389/fonc.2015.00195
Argyropulo-Palmer, Miriam, et al. "Sunitinib in Metastatic Renal Cell Carcinoma: A Systematic Review of UK Real World Data." Frontiers in oncology vol. 5 (2015): 195. doi: https://doi.org/10.3389/fonc.2015.00195
Argyropulo-Palmer M, Jenkins A, Theti DS, Larkin J, Montgomery D. Sunitinib in Metastatic Renal Cell Carcinoma: A Systematic Review of UK Real World Data. Front Oncol. 2015 Aug 25;5:195. doi: 10.3389/fonc.2015.00195. eCollection 2015. PMID: 26380224; PMCID: PMC4548684.
Copy Download .nbib Format: NLM
An evidence-based conceptual framework of healthy cooking.

Preventive medicine reports

Raber M, Chandra J, Upadhyaya M, Schick V, Strong LL, Durand C, Sharma S.
PMID: 27413657
Prev Med Rep. 2016 May 17;4:23-8. doi: 10.1016/j.pmedr.2016.05.004. eCollection 2016 Dec.

Eating out of the home has been positively associated with body weight, obesity, and poor diet quality. While cooking at home has declined steadily over the last several decades, the benefits of home cooking have gained attention in recent...

Cite
Raber M, Chandra J, Upadhyaya M, et al. An evidence-based conceptual framework of healthy cooking. Prev Med Rep. 2016;4:23-8doi: 10.1016/j.pmedr.2016.05.004.
Raber, M., Chandra, J., Upadhyaya, M., Schick, V., Strong, L. L., Durand, C., & Sharma, S. (2016). An evidence-based conceptual framework of healthy cooking. Preventive medicine reports, 423-8. https://doi.org/10.1016/j.pmedr.2016.05.004
Raber, Margaret, et al. "An evidence-based conceptual framework of healthy cooking." Preventive medicine reports vol. 4 (2016): 23-8. doi: https://doi.org/10.1016/j.pmedr.2016.05.004
Raber M, Chandra J, Upadhyaya M, Schick V, Strong LL, Durand C, Sharma S. An evidence-based conceptual framework of healthy cooking. Prev Med Rep. 2016 May 17;4:23-8. doi: 10.1016/j.pmedr.2016.05.004. eCollection 2016 Dec. PMID: 27413657; PMCID: PMC4929050.
Copy Download .nbib Format: NLM
Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.

Contemporary clinical trials

Ledgerwood JE, Hu Z, Costner P, Yamshchikov G, Enama ME, Plummer S, Hendel CS, Holman L, Larkin B, Gordon I, Bailer RT, Poretz DM, Sarwar U, Kabadi A, Koup R, Mascola JR, Graham BS.
PMID: 26275339
Contemp Clin Trials. 2015 Sep;44:112-118. doi: 10.1016/j.cct.2015.08.006. Epub 2015 Aug 12.

Annual influenza vaccination reduces the risks of influenza when the vaccines are well matched to circulating strains, but development of an approach that induces broader and more durable immune responses would be beneficial. We conducted two companion Phase 1...

Cite
Ledgerwood JE, Hu Z, Costner P, et al. Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost. Contemp Clin Trials. 2015;44:112-118doi: 10.1016/j.cct.2015.08.006.
Ledgerwood, J. E., Hu, Z., Costner, P., Yamshchikov, G., Enama, M. E., Plummer, S., Hendel, C. S., Holman, L., Larkin, B., Gordon, I., Bailer, R. T., Poretz, D. M., Sarwar, U., Kabadi, A., Koup, R., Mascola, J. R., Graham, B. S. (2015). Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost. Contemporary clinical trials, 44112-118. https://doi.org/10.1016/j.cct.2015.08.006
Ledgerwood, Julie E, et al. "Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost." Contemporary clinical trials vol. 44 (2015): 112-118. doi: https://doi.org/10.1016/j.cct.2015.08.006
Ledgerwood JE, Hu Z, Costner P, Yamshchikov G, Enama ME, Plummer S, Hendel CS, Holman L, Larkin B, Gordon I, Bailer RT, Poretz DM, Sarwar U, Kabadi A, Koup R, Mascola JR, Graham BS. Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost. Contemp Clin Trials. 2015 Sep;44:112-118. doi: 10.1016/j.cct.2015.08.006. Epub 2015 Aug 12. PMID: 26275339; PMCID: PMC4751067.
Copy Download .nbib Format: NLM
Contemporary Strategies for Detecting Chlamydial Infection in Women.

Medscape women's health

Toney JF, Larkin J.
PMID: 9746626
Medscape Womens Health. 1996 May;1(5):1.

Chlamydia trachomatis infections are the most common bacterial cause of sexually transmitted disease in the US. In women, these infections often result in such serious reproductive tract complications as pelvic inflammatory disease, infertility, and ectopic pregnancy, and an infected...

Cite
Toney JF, Larkin J. Contemporary Strategies for Detecting Chlamydial Infection in Women. Medscape Womens Health. 1996;1(5):1
Toney, J. F., & Larkin, J. (1996). Contemporary Strategies for Detecting Chlamydial Infection in Women. Medscape women's health, 1(5), 1.
Toney, and Larkin. "Contemporary Strategies for Detecting Chlamydial Infection in Women." Medscape women's health vol. 1,5 (1996): 1.
Toney JF, Larkin J. Contemporary Strategies for Detecting Chlamydial Infection in Women. Medscape Womens Health. 1996 May;1(5):1. PMID: 9746626.
Copy Download .nbib Format: NLM
Countering alternative medicine.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde

Barlin H.
PMID: 7839224
S Afr Med J. 1993 Nov;83(11):860-1.

No abstract available.

Cite
Barlin H. Countering alternative medicine. S Afr Med J. 1993;83(11):860-1
Barlin, H. (1993). Countering alternative medicine. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 83(11), 860-1.
Barlin, H. "Countering alternative medicine." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde vol. 83,11 (1993): 860-1.
Barlin H. Countering alternative medicine. S Afr Med J. 1993 Nov;83(11):860-1. PMID: 7839224.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 504 entries